Tariff Tensions & AI Optimism — Neutral S&P 500 as Canada & Mexico Retaliate, Boston Scientific Expands with $360M SoniVie Deal, CRC Reports Strong 2024 Amid Sustainability Push.
Happy Monday, everyone! 🎉 I’m excited to share that our team has upgraded the Analytics Dashboard! The enhanced dashboard now provides a powerful high-level view of market trends and key AI events, helping you stay ahead of the game. Check it out if you haven’t already!
By clicking on the ads, you’re directly supporting us to keep delivering quality content and insights, while also helping us earn revenue to continue our work. Every click makes a difference—thank you for your support!
Invest with the art investment platform with 23 profitable exits.
How has the art investing platform Masterworks been able to realize an individual profit for investors with each of its 23 exits to date?
Here’s an example: an exited Banksy was offered to investors at $1.039 million and internally appraised at the same value after acquisition. As Banksy’s market took off, Masterworks received an offer of $1.5 million from a private collector, resulting in 32% net annualized return for investors in the offering.
Every artwork performs differently — but with 3 illustrative sales (that were held for 1+ year), Masterworks investors realized net annualized returns of 17.6%, 17.8%, and 21.5%.
Masterworks takes care of the heavy lifting: from buying the paintings, to storing them, to selling them for you (no art experience required).
Past performance not indicative of future returns. Investing Involves Risk. See Important Disclosures at masterworks.com/cd.
Remember to move the mail to the Primary inbox if this mail is in other inboxes.
Here’re the stocks with notable attention/movement for today, 3/3.
Overall, our AI maintains a neutral stance on general market news while showing a bullish outlook on today’s AI-related events.
Here’s a breakdown of key stock events by our AI Event signal for today, 3/3.
Top 3 Must-Know News Stories for Today, 3/3.
Our AI cuts through the noise, saving you 13 minutes by delivering the heart of today’s events in seconds!
Market Watch
BearishShortTermS&P 500Economics
Here’s what the U.S. exports to Canada and Mexico, as those countries threaten retaliatory tariffs - MarketWatch
- New tariffs from the U.S. on Canada and Mexico are threatened.
- Canada plans tariffs on $20 billion of U.S. goods, escalating to $85 billion.
- Mexico also indicates its own tariffs in response to U.S. policies.
- S&P 500 remained steady amid uncertainty over these tariff plans.
- Manufacturing data was weaker than expected, further impacting investor sentiment.
PRNewsWire
BullishLongTermBSXM&A
Boston Scientific announces agreement to acquire SoniVie Ltd.
- Boston Scientific to acquire SoniVie for $360 million upfront.
- Acquisition enhances catheter-based renal denervation therapy for hypertension.
- TIVUS system shows promise in clinical trials for treating hypertension.
- Deal may slightly dilute EPS in 2025 but aims for internal efficiencies.
- Completion expected by first half of 2025, pending regulatory approval.
GlobeNewsWire
BullishShortTermCRCEarnings
California Resources Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
- CRC reports strong 2024 financial results and significant capital efficiency improvements.
- Generated $610 million net cash flow in 2024, continuing momentum from the Aera merger.
- Announced $285-335 million capital investments and 132-138 MBoe/d production guidance for 2025.
- Received first EPA Class VI well permits for CO2 management, highlighting sustainability advancements.
- Returned $303 million to shareholders in 2024 through dividends and share buybacks.
Like StockNews.AI? Unlock more functions by joining our Premium or Pro Plan 🏠 🙌
Disclaimer: The content provided in this Email should be used for informational purposes only and in no way should be relied upon for financial advice.
Reply